451
Views
36
CrossRef citations to date
0
Altmetric
Review

Medulloblastoma: optimizing care with a multidisciplinary approach

&
Pages 335-347 | Published online: 30 Apr 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

L. Torrisi, M. Davidkova, V. Havranek, M. Cutroneo & A. Torrisi. (2020) Physical study of proton therapy at CANAM laboratory on medulloblastoma cell lines DAOY. Radiation Effects and Defects in Solids 175:9-10, pages 863-878.
Read now

Articles from other publishers (35)

Soheir M. Hamam, Eman Abdelzaher, Shady H. Fadel, Rasha A. Nassra & Hend A. Sharafeldin. (2023) Prognostic value of microRNA-125a expression status in molecular groups of pediatric medulloblastoma. Child's Nervous System 39:7, pages 1869-1880.
Crossref
Leon F. McSwain, Claire E. Pillsbury, Ramona Haji-Seyed-Javadi, Sandip Kumar Rath, Victor Chen, Tiffany Huang, Shubin W. Shahab, Haritha Kunhiraman, James Ross, Gabrielle A. Price, Abhinav Dey, Dolores Hambardzumyan, Tobey MacDonald, David S. Yu, Christopher C. Porter & Anna M. Kenney. (2023) YB1 modulates the DNA damage response in medulloblastoma. Scientific Reports 13:1.
Crossref
Lorenzo Manfreda, Elena Rampazzo & Luca Persano. (2023) Wnt Signaling in Brain Tumors: A Challenging Therapeutic Target. Biology 12:5, pages 729.
Crossref
Jerome H. Alcantara, Eric David B. Ornos & Ourlad Alzeus G. Tantengco. (2023) Global trends, gaps, and future agenda in medulloblastoma research: a bibliometric analysis. Child's Nervous System.
Crossref
Ilaria Bertacca, Francesco Pegoraro, Annalisa Tondo & Claudio Favre. (2023) Targeted treatment of solid tumors in pediatric precision oncology. Frontiers in Oncology 13.
Crossref
Nicolina Jovanovich, Ahmed Habib, NU Farrukh Hameed, Lincoln Edwards & Pascal O Zinn. (2023) Applications and current challenges of chimeric antigen receptor T cells in treating high-grade gliomas in adult and pediatric populations. Immunotherapy 15:5, pages 383-396.
Crossref
Chaemin Lim, Jain Koo & Kyung Taek Oh. (2022) Nanomedicine approaches for medulloblastoma therapy. Journal of Pharmaceutical Investigation 53:2, pages 213-233.
Crossref
Ghita Hatim, Tarik Chekrine, Majdouline Houjami, Sofia Karami, Zineb Bouchbika, Nadia Benchakroun, Hassan Jouhadi, Nezha Tawfiq, Said Hilmani, Mehdi Karkouri, Abdelhakim Lakhdar, Abdelatif Benider & Souha Sahraoui. (2022) Adult's Medulloblastoma. European Journal of Medical and Health Sciences 4:5, pages 44-47.
Crossref
Paula Martín-Rubio, Pilar Espiau-Romera, Alba Royo-García, Laia Caja & Patricia Sancho. (2022) Metabolic determinants of stemness in medulloblastoma. World Journal of Stem Cells 14:8, pages 587-598.
Crossref
Sagun Parakh, Amy Davies, Kerryn Westcott, Daniel Roos, Amal Abou-Hamden, Elizabeth Ahern, Peter K.H. Lau, Sowmya Cheruvu, Ganesalingam Pranavan, Andrew Pullar, James Lynam, Cecelia Gzell, James R. Whittle, Sarah Cain, Po-ling Inglis, Rosemary Harrup, Antoinette Anazodo, Elizabeth Hovey, Lawrence Cher & Hui K. Gan. (2022) Adult medulloblastoma in an Australian population. Journal of Clinical Neuroscience 102, pages 65-70.
Crossref
Yan-Xia Wang, Haibo Wu, Yong Ren, Shengqing Lv, Chengdong Ji, Dongfang Xiang, Mengsi Zhang, Huimin Lu, Wenjuan Fu, Qing Liu, Zexuan Yan, Qinghua Ma, Jingya Miao, Ruili Cai, Xi Lan, Bin Wu, Wenying Wang, Yinhua Liu, Dai-Zhong Wang, Mianfu Cao, Zhicheng He, Yu Shi, Yifang Ping, Xiaohong Yao, Xia Zhang, Peng Zhang, Ji Ming Wang, Yan Wang, Youhong Cui & Xiu-Wu Bian. (2022) Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas. Signal Transduction and Targeted Therapy 7:1.
Crossref
Sabina Quader, Kazunori Kataoka & Horacio Cabral. (2022) Nanomedicine for brain cancer. Advanced Drug Delivery Reviews 182, pages 114115.
Crossref
Sanjay P. Prabhu & Tina Young Poussaint. 2022. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging 739 765 .
Pinelopi Gkogkou & Thankamma V. Ajithkumar. 2022. Pediatric Neurosurgery for Clinicians. Pediatric Neurosurgery for Clinicians 813 838 .
Yavuz Aras, Duygu Dölen, Ayca İribas Çelik, Gozde Kılıç, Rejin Kebudi, Gökçen Ünverengil, Pulat Akın Sabancı & Ali Nail İzgi. (2021) Effects of different molecular subtypes and tumor biology on the prognosis of medulloblastoma. Child's Nervous System 37:12, pages 3733-3742.
Crossref
Cristina Ferreras, Lucía Fernández, Laura Clares-Villa, Marta Ibáñez-Navarro, Carla Martín-Cortázar, Isabel Esteban-Rodríguez, Javier Saceda & Antonio Pérez-Martínez. (2021) Facing CAR T Cell Challenges on the Deadliest Paediatric Brain Tumours. Cells 10:11, pages 2940.
Crossref
Alexander P. Landry, Nardin Samuel, Julian Spears & Zsolt Zador. (2021) Integrated computational analyses reveal novel insights into the stromal microenvironment of SHH-subtype medulloblastoma. Scientific Reports 11:1.
Crossref
Ramy Ayoub, Kaylie Lau, Nili Yuen, Darren Fernandes, Madeline Elder, Jonas Yeung, Shun C. Wong & Brian J. Nieman. (2021) Spatiotemporal Mapping of Early Volume Loss in the Mouse Brain after Cranial Irradiation. Radiation Research 196:4.
Crossref
Valeria Simone, Daniela Rizzo, Alessandro Cocciolo, Anna Maria Caroleo, Andrea Carai, Angela Mastronuzzi & Assunta Tornesello. (2021) Infantile Brain Tumors: A Review of Literature and Future Perspectives. Diagnostics 11:4, pages 670.
Crossref
Dimitrios Panagopoulos, Ploutarchos Karydakis, Dimitrios Giakoumettis & Marios Themistocleous. (2021) The 100 most cited papers about medulloblastomas. Interdisciplinary Neurosurgery 23, pages 100855.
Crossref
B. Grassiot, P.A. Beuriat, F. Di Rocco, P. Leblond, C. Faure-Conter, A. Szathmari & C. Mottolese. (2021) Surgical management of posterior fossa medulloblastoma in children: The Lyon experience. Neurochirurgie 67:1, pages 52-60.
Crossref
Marko Jug. (2021) A 3D-Printed Model-Assisted Cervical Spine Instrumentation after Tumor Resection in a 4-Year-Old Child: A Case Report. Pediatric Neurosurgery 56:3, pages 254-260.
Crossref
Hussein Hammoud, Zahraa Saker, Hayat Harati, Youssef Fares, Hisham F. Bahmad & Sanaa Nabha. (2020) Drug Repurposing in Medulloblastoma: Challenges and Recommendations. Current Treatment Options in Oncology 22:1.
Crossref
Jiajia Wang, Yi Sui, Qifeng Li, Yang Zhao, Xiaoshu Dong, Jian Yang, Zhuangzhuang Liang, Yipeng Han, Yujie Tang & Jie Ma. (2020) Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137. Cell Death & Disease 11:12.
Crossref
Pavan Kumar Dhanyamraju, Trupti N. Patel & Sinisa Dovat. (2020) Medulloblastoma: “Onset of the molecular era”. Molecular Biology Reports 47:12, pages 9931-9937.
Crossref
Mohammed Sedeeq, Ahmed Maklad, Nuri Gueven & Iman Azimi. (2020) Development of a High-throughput Agar Colony Formation Assay to Identify Drug Candidates against Medulloblastoma. Pharmaceuticals 13:11, pages 368.
Crossref
Komal S. Rathi, Sherjeel Arif, Mateusz Koptyra, Ammar S. Naqvi, Deanne M. Taylor, Phillip B. Storm, Adam C. Resnick, Jo Lynne Rokita & Pichai Raman. (2020) A transcriptome-based classifier to determine molecular subtypes in medulloblastoma. PLOS Computational Biology 16:10, pages e1008263.
Crossref
Zoheir Reihanian, Hamid Behzadnia, Ahmad Kheiri Namin & Nooshin Zaresharifi. (2020) A Rare Case of Medulloblastoma with Supratentorial Metastasis Two Years after Treatment. Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 39:03, pages 235-238.
Crossref
S. Naganawa, T. Donohue, A. Capizzano, Y. Ota, J. Kim, A. Srinivasan & T. Moritani. (2020) Neuroradiology Manifestations of Li-Fraumeni Syndrome: Epidemiology, Genetics, Imaging Findings, and Management. Neurographics 10:4, pages 228-235.
Crossref
Ji Won Lee, Do Hoon Lim, Ki Woong Sung, Hee Won Cho, Hee Young Ju, Ju Kyung Hyun, Keon Hee Yoo, Hong Hoe Koo, Yeon‐Lim Suh, Yoo‐Sook Joung & Hyung Jin Shin. (2020) Promising survival rate but high incidence of treatment‐related mortality after reduced‐dose craniospinal radiotherapy and tandem high‐dose chemotherapy in patients with high‐risk medulloblastoma. Cancer Medicine 9:16, pages 5807-5818.
Crossref
Andreas Kloetgen, Sujitha Duggimpudi, Konstantin Schuschel, Kebria Hezaveh, Daniel Picard, Heiner Schaal, Marc Remke, Jan-Henning Klusmann, Arndt Borkhardt, Alice C. McHardy & Jessica I. Hoell. (2020) YBX1 Indirectly Targets Heterochromatin-Repressed Inflammatory Response-Related Apoptosis Genes through Regulating CBX5 mRNA. International Journal of Molecular Sciences 21:12, pages 4453.
Crossref
Han Zou, Brad Poore, Alberto Broniscer, Ian F. Pollack & Baoli Hu. (2020) Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma. Cancers 12:3, pages 643.
Crossref
Hisham F. Bahmad, Mohamad K. Elajami, Talal El Zarif, Jolie Bou-Gharios, Tamara Abou-Antoun & Wassim Abou-Kheir. (2020) Drug repurposing towards targeting cancer stem cells in pediatric brain tumors. Cancer and Metastasis Reviews 39:1, pages 127-148.
Crossref
ZealD Rawal, VinalA Upadhyay, DipakD Patel & TruptiI Trivedi. (2020) Medulloblastoma under siege: Genetic and molecular dissection concerning recent advances in therapeutic strategies. Journal of Pediatric Neurosciences 15:3, pages 175.
Crossref
Rachel Lampe, Miranda D. Vieson, Devon Hague, Dana Connell, Kari Foss & Kim A. Selting. (2019) Medulloblastoma in a 6 Year Old Mixed Breed Dog: Surgical Debulking and Chemotherapy. Frontiers in Veterinary Science 6.
Crossref